Clinical liver disease

Keyphrases

Publications

volume 22, number 1, 2023

volume 22, number 2, 2023

Henry Kibble, Debbie Lindsay Shawcross
The microbiome in portal hypertension. Clinical liver disease 22 (2) (2023)
Frances Lee, Tarun Rustagi, R Todd Frederick
Endo-hepatology: Updates for the clinical hepatologist. Clinical liver disease 22 (2) (2023)
Kevin Tang, Ethan M Weinberg
Direct oral anticoagulants in the treatment of portal vein thrombosis in patients with portal hypertension. Clinical liver disease 22 (2) (2023)
Neha Tiwari, Florence S H Wong
Hepatorenal syndrome: Updates. Clinical liver disease 22 (2) (2023)
Apoorva Gogna, Hiang Keat Tan, Chow Wei Too, Pik-Eu Jason Chang
IR management of portal hypertension complications. Clinical liver disease 22 (2) (2023)
Akash Roy, Ashirwad Pasumarthy, Anand V Kulkarni
Updates in noncirrhotic portal hypertension. Clinical liver disease 22 (2) (2023)
Maria Mironova, Christopher Koh
Noninvasive measures of portal hypertension. Clinical liver disease 22 (2) (2023)
Jordi Gratacós-Ginès, Elisa Pose
Review of the role of statins in cirrhosis and portal hypertension. Clinical liver disease 22 (2) (2023)

volume 22, number 3, 2023

Elizabeth Lee, Huttakan Navadurong, Suthat Liangpunsakul
Epidemiology and trends of alcohol use disorder and alcohol-associated liver disease. Clinical liver disease 22 (3) (2023)
Samhita Ravi, Maria Hernandez-Tejero, Hugo López Pelayo, Ramon A Bataller
Psychological interventions to treat alcohol use disorder in patients with liver disease. Clinical liver disease 22 (3) (2023)
Todd Doyle, Benjamin Schmidt, Steve Scaglione
Prevalence of depression and anxiety symptoms by liver disease etiology. Clinical liver disease 22 (3) (2023)
Meghan D Morris, Claire McDonell, Rebecca G Kim, Yesenia Laguardia, Rachel Kanner, Jennifer C Price
A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs. Clinical liver disease 22 (3) (2023)
Kenneth W Chow, Mark Ebaid, Brittney M Ibrahim, Sammy Saab
Epidemiology and outcomes of non-alcoholic fatty liver disease in African Americans. Clinical liver disease 22 (3) (2023)
Kyaw Min Tun, Nabil Noureddin, Mazen Noureddin
Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review. Clinical liver disease 22 (3) (2023)
Elizabeth S Aby, Anjana A Pillai
HiCCups in management-Pitfalls and pearls for the management of HCC. Clinical liver disease 22 (3) (2023)

volume 22, number 4, 2023

Phillip Chen, Douglas A Simonetto, Sonali Paul, Arpan A Patel
Health disparities experienced by sexual and gender minority individuals living with or at risk of chronic liver disease. Clinical liver disease 22 (4) (2023)
Ghulam Nabi Yattoo, Syed Mushfiq Shafi, Gulzar Ahmad Dar, Jaswinder Singh Sodhi, Suresh Gorka, Neeraj Dhar, Shaheena Nazir, Asif Iqbal Shah, Deeba Shah
Safety and efficacy of treatment for chronic hepatitis C during pregnancy: A prospective observational study in Srinagar, India. Clinical liver disease 22 (4) (2023)
Moira B Hilscher, Patrick S Kamath
Fontan-associated liver disease. Clinical liver disease 22 (4) (2023)
Thomas Hunold, Anjana A Pillai
Current updates in HCC screening and treatment. Clinical liver disease 22 (4) (2023)
Sasha Deutsch-Link, Patrick T Campbell, Neil D Shah
PRO: Ascitic fluid cell count should be routinely sent with every therapeutic paracentesis to assess for spontaneous bacterial peritonitis. Clinical liver disease 22 (4) (2023)
Jihad Aljabban, William J Burlingham, Michael R Lucey
The potential role of infusions of T regulatory cells in inducing and maintaining liver allograft tolerance. Clinical liver disease 22 (4) (2023)
Nabeeha Mohy-Ud-Din, Alan Noll, Naudia Jonassaint
CON: Ascitic fluid cell count should not be routinely sent with every therapeutic paracentesis to assess for spontaneous bacterial peritonitis. Clinical liver disease 22 (4) (2023)
Areej Mazhar, Marc S Piper
Updates on Wilson disease. Clinical liver disease 22 (4) (2023)

volume 22, number 5, 2023

Nawid Sayed, Jennifer A Flemming
Cirrhosis in pregnancy. Clinical liver disease 22 (5) (2023)
Christine Tien, Hyosun H Han
Current status and challenges of living donor liver transplantation in the United States. Clinical liver disease 22 (5) (2023)
Himesh B Zaver, Tushar C Patel
Opportunities for the use of large language models in hepatology. Clinical liver disease 22 (5) (2023)
Karim T Osman, Julie T Nguyen, Avignat S Patel, Amir A Qamar
The clinician's dilemma with spontaneous bacterial empyema. Clinical liver disease 22 (5) (2023)
Sofi Damjanovska, Daniel B Karb, Stanley M Cohen
Delivering health care education and information about excessive alcohol consumption and risks of alcohol-associated liver disease. Clinical liver disease 22 (5) (2023)
Nabeel Wahid, Andres Duarte-Rojo, Justin R Boike
Terlipressin for hepatorenal syndrome: The practical choice for clinicians. Clinical liver disease 22 (5) (2023)
Manida Wungjiranirun, Nicole Wong, Janice Jou, Cynthia A Moylan
Updates in nonalcoholic fatty liver disease. Clinical liver disease 22 (5) (2023)
Mounika Kanneganti, Amit G Singal
Diagnosis and management of indeterminate liver nodules in patients with cirrhosis. Clinical liver disease 22 (5) (2023)

volume 21, number 6, 2023

Anahita Rabiee, Anahita Rabiee, Jessica P E Davis
Brief overview of immunosuppression and its side effects after liver transplantation. Clinical liver disease 21 (6) (2023)
Omobonike O Oloruntoba, Sajal D Tanna
Evaluation and management of post-transplant infections for the hepatologist. Clinical liver disease 21 (6) (2023)
Dana Ley, Jessica Musto
Immunizations in liver transplant candidates. Clinical liver disease 21 (6) (2023)
Rahul Mohan, Jonathan Rice
A practical approach to extrahepatic cancer screening before and after liver transplant. Clinical liver disease 21 (6) (2023)
Apaar Dadlani, Tzu-Hao Lee
Management of metabolic syndrome after liver transplant. Clinical liver disease 21 (6) (2023)
Armando Bosch, Kimberly E Daniel
Pregnancy and contraception in the post-liver transplant patient. Clinical liver disease 21 (6) (2023)
Emily Harding-Theobald, Michael S Kriss
Evaluation and management of abnormal liver enzymes in the liver transplant recipient: When, why, and what now? Clinical liver disease 21 (6) (2023)
Carolyn Ahlers, Matthew Robert Kappus
Obesity management for the pre-liver transplant and post-liver transplant patient. Clinical liver disease 21 (6) (2023)
Emily Harding-Theobald, Michael S Kriss
Evaluation and management of abnormal liver enzymes in the liver transplant recipient: When, why, and what now? Clinical liver disease 21 (6) (2023)
Rahul Mohan, Jonathan Rice
A practical approach to extrahepatic cancer screening before and after liver transplant. Clinical liver disease 21 (6) (2023)
Armando Bosch, Kimberly E Daniel
Pregnancy and contraception in the post-liver transplant patient. Clinical liver disease 21 (6) (2023)
Carolyn Ahlers, Matthew Robert Kappus
Obesity management for the pre-liver transplant and post-liver transplant patient. Clinical liver disease 21 (6) (2023)
Omobonike O Oloruntoba, Sajal D Tanna
Evaluation and management of post-transplant infections for the hepatologist. Clinical liver disease 21 (6) (2023)